Neurolytril en es it fr

Neurolytril Brand names, Neurolytril Analogs

Neurolytril Brand Names Mixture

  • No information avaliable

Neurolytril Chemical_Formula


Neurolytril RX_link

Neurolytril fda sheet

Neurolytril msds (material safety sheet)

Neurolytril MSDS

Neurolytril Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Neurolytril Molecular Weight

284.74 g/mol

Neurolytril Melting Point


Neurolytril H2O Solubility

Slightly soluble (50 mg/L)

Neurolytril State


Neurolytril LogP


Neurolytril Dosage Forms

Tablets; Injectable solution

Neurolytril Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Neurolytril Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Neurolytril Absorption

Essentially complete, with a bioavailability of 93%.

Neurolytril side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Neurolytril Patient Information

Neurolytril Organisms Affected

Humans and other mammals